These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8339601)

  • 1. In vitro leucocytotoxicity of alpha-hemolytic Escherichia coli.
    Gadeberg OV
    Dan Med Bull; 1993 Jun; 40(3):295-305. PubMed ID: 8339601
    [No Abstract]   [Full Text] [Related]  

  • 2. [Escherichia coli hemolysin: secretion kinetics and cytotoxic effect].
    Abacioğlu H; Yuluğ N
    Mikrobiyol Bul; 1993 Oct; 27(4):284-93. PubMed ID: 8264441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes. Correlation with size of alpha-hemolysin production.
    Gadeberg OV; Larsen SO
    APMIS; 1988 Apr; 96(4):337-41. PubMed ID: 2897205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental regulation of alpha-haemolysin expression in Escherichia coli.
    Mouriño M; Muñoa F; Balsalobre C; Diaz P; Madrid C; Juarez A
    Microb Pathog; 1994 Apr; 16(4):249-59. PubMed ID: 7968454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Escherichia coli alpha-hemolysin to bacterial virulence and to intraperitoneal alterations in peritonitis.
    May AK; Gleason TG; Sawyer RG; Pruett TL
    Infect Immun; 2000 Jan; 68(1):176-83. PubMed ID: 10603385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.
    Gleason TG; Houlgrave CW; May AK; Crabtree TD; Sawyer RG; Denham W; Norman JG; Pruett TL
    Infect Immun; 1998 Sep; 66(9):4215-21. PubMed ID: 9712770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the roles of hemolysin and other toxins in enteropathy caused by alpha-hemolytic Escherichia coli linked to human diarrhea.
    Elliott SJ; Srinivas S; Albert MJ; Alam K; Robins-Browne RM; Gunzburg ST; Mee BJ; Chang BJ
    Infect Immun; 1998 May; 66(5):2040-51. PubMed ID: 9573087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants.
    May AK; Sawyer RG; Gleason T; Whitworth A; Pruett TL
    Infect Immun; 1996 Jun; 64(6):2167-71. PubMed ID: 8675322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial hemolysins and leukotoxins affect target cells by forming large exogenous pores into their plasma membrane: Escherichia coli hemolysin A as a case example.
    Menestrina G; Dalla Serra M; Pederzolli C; Bregante M; Gambale F
    Biosci Rep; 1995 Dec; 15(6):543-51. PubMed ID: 9156583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxigenic Escherichia coli.
    Chart H
    Symp Ser Soc Appl Microbiol; 1998; 27():77S-86S. PubMed ID: 9750364
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of phagocytosis of alpha hemolytic strains of Escherichia coli using the fluorescence method].
    Siegfried L; Puzová H; Hlaucová J; Durovicová J
    Cesk Epidemiol Mikrobiol Imunol; 1989 Jul; 38(4):204-8. PubMed ID: 2676198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolysins and verotoxin (VT) in enteric Escherichia coli isolated from pigs.
    Zamora J; Reinhardt G; Polette M; Macías P
    Rev Latinoam Microbiol; 1997; 39(3-4):159-65. PubMed ID: 10932726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction fragment length polymorphisms associated with alpha-hemolysin determinants are correlating with the expression of alpha-hemolysin in strains of Escherichia coli.
    Prada J; Zimmermann S; Stephan R; Beutin L
    Zentralbl Bakteriol; 1992 Jan; 276(2):152-64. PubMed ID: 1348436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acylation of two internal lysine residues required for the toxic activity of Escherichia coli hemolysin.
    Stanley P; Packman LC; Koronakis V; Hughes C
    Science; 1994 Dec; 266(5193):1992-6. PubMed ID: 7801126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic applications of pore-forming lytic toxins: potential use of Escherichia coli alpha-hemolysin].
    Herlax V; Bakas LS
    Medicina (B Aires); 2002; 62(1):66-72. PubMed ID: 11965855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum resistance of Escherichia coli strains causing urinary tract infection and diarrhoea in relation to alpha haemolysin production and O type.
    Rizvi M; Kumar S
    Indian J Pathol Microbiol; 2003 Jul; 46(3):504-6. PubMed ID: 15025325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of sepsis syndrome: possible relevance of pore-forming bacterial toxins.
    Bhakdi S; Walev I; Jonas D; Palmer M; Weller U; Suttorp N; Grimminger F; Seeger W
    Curr Top Microbiol Immunol; 1996; 216():101-18. PubMed ID: 8791737
    [No Abstract]   [Full Text] [Related]  

  • 18. The biochemistry of hemolysin toxin activation: characterization of HlyC, an internal protein acyltransferase.
    Trent MS; Worsham LM; Ernst-Fonberg ML
    Biochemistry; 1998 Mar; 37(13):4644-52. PubMed ID: 9521785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis and function of the Escherichia coli hemolysin and related RTX exotoxins.
    Welch RA; Forestier C; Lobo A; Pellett S; Thomas W; Rowe G
    FEMS Microbiol Immunol; 1992 Sep; 5(1-3):29-36. PubMed ID: 1419112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dangerous signals from E. coli toxin.
    Ludwig A; Goebel W
    Nat Med; 2000 Jul; 6(7):741-2. PubMed ID: 10888915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.